• Aug 3, 2025 who classification of tumours of the urinary syst urs based on their tissue of origin, cellular morphology, and biological behavior. This systematic approach enhances diagnostic accuracy and facilitates communication among healthcare providers. The WHO classificati By Sydnee Rolfson
• Oct 4, 2025 who classification of tumours of the lung pleura ) Pleura (mesothelial tumours) Other rare tumours of the lung and pleura Understanding these categories is essential for accurate diagnosis and appropriate management. Classification of Tumours of the Lung L By Dr. Travis Waters
• Mar 26, 2026 who classification of tumours of soft tissue and on system is crucial because soft tissue tumors encompass more than 50 different entities, each with unique histological and molecular features. Origins and Development of the WHO Classification Historical Perspective The clas By Dana Buckridge
• Nov 30, 2025 who classification of tumours of endocrine organs sification, pancreatic neuroendocrine tumors are categorized into well-differentiated neuroendocrine tumors (NETs) grades 1 and 2, poorly differentiated neuroendocrine carcinomas (NECs), and mixed neuroendocrine-non-ne By Dovie Schimmel
• May 24, 2026 who classification of skin tumours ematolymphoid Tumours These are rare but include lymphomas and leukaemias that involve the skin. Cutaneous T-cell lymphomas (e.g., mycosis fungoides) Other lymphoproliferative disorders Subclassification of Malignant Skin Tumours Under By Bertha Murray
• Sep 29, 2025 who classification of endocrine tumours l and molecular framework that categorizes tumors based on their origin, cellular differentiation, malignancy potential, and molecular features. The system emphasizes a multidisciplinary approach, combining mor By Mr. Carlie Dooley
